- Home
- RVMD vs ENSG Comparison
RVMD vs ENSG Comparison
Compare RVMD & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- ENSG
- Stock Information
- Founded
- RVMD 2014
- ENSG 1999
- Country
- RVMD United States
- ENSG United States
- Employees
- RVMD N/A
- ENSG N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- ENSG Hospital/Nursing Management
- Sector
- RVMD Health Care
- ENSG Health Care
- Exchange
- RVMD Nasdaq
- ENSG Nasdaq
- Market Cap
- RVMD 7.5B
- ENSG 8.9B
- IPO Year
- RVMD 2020
- ENSG 2007
- Fundamental
- Price
- RVMD $38.27
- ENSG $172.60
- Analyst Decision
- RVMD Strong Buy
- ENSG Buy
- Analyst Count
- RVMD 13
- ENSG 7
- Target Price
- RVMD $69.85
- ENSG $170.43
- AVG Volume (30 Days)
- RVMD 1.9M
- ENSG 381.8K
- Earning Date
- RVMD 08-06-2025
- ENSG 10-23-2025
- Dividend Yield
- RVMD N/A
- ENSG 0.14%
- EPS Growth
- RVMD N/A
- ENSG 41.66
- EPS
- RVMD N/A
- ENSG 5.52
- Revenue
- RVMD N/A
- ENSG $4,614,838,000.00
- Revenue This Year
- RVMD N/A
- ENSG $19.59
- Revenue Next Year
- RVMD $387.56
- ENSG $10.78
- P/E Ratio
- RVMD N/A
- ENSG $31.26
- Revenue Growth
- RVMD N/A
- ENSG 16.31
- 52 Week Low
- RVMD $29.17
- ENSG $118.73
- 52 Week High
- RVMD $62.40
- ENSG $173.62
- Technical
- Relative Strength Index (RSI)
- RVMD 58.95
- ENSG 73.70
- Support Level
- RVMD $35.62
- ENSG $169.01
- Resistance Level
- RVMD $37.91
- ENSG $173.62
- Average True Range (ATR)
- RVMD 1.29
- ENSG 2.80
- MACD
- RVMD 0.32
- ENSG 0.33
- Stochastic Oscillator
- RVMD 100.00
- ENSG 92.74
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.